Skip to main content
. 2022 May 26;9:854107. doi: 10.3389/fcvm.2022.854107

FIGURE 4.

FIGURE 4

Restricted cubic spline curve for the risk in diabetic patients according to big ET-1; (A) major adverse cardiovascular events [MACE; adjusted for age, sex, left ventricular ejection fraction (LVEF), in-stent restenosis (ISR) duration, hypertension, drug-eluting stent (DES) intervention, total cholesterol (TC), and diameter stenosis rate]; (B) secondary end points [adjusted for age, sex, high-density lipoprotein cholesterol (HDL-c), TC, reference vessel diameter, target lesion length, and diameter stenosis rate].